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Abstract
Background: Wildebeest associated malignant catarrhal fever (WA-MCF) is a fatal disease of cattle. Outbreaks are
seasonal and associated with close interaction between cattle and calving wildebeest. In Kenya, WA-MCF has a
dramatic effect on cattle-keepers who lose up to 10% of their cattle herds per year. The objective of this study was
to report the impact of WA-MCF on a commercial ranch and assess the performance of clinical diagnosis compared
to laboratory diagnosis as a disease management tool.
A retrospective study of WA-MCF in cattle was conducted from 2014 to 2016 at Kapiti Plains Ranch Ltd., Kenya.
During this period, 325 animals showed clinical signs of WA-MCF and of these, 123 were opportunistically sampled.
In addition, 51 clinically healthy animals were sampled. Nested polymerase chain reaction (PCR) and indirect
enzyme linked immunosorbent assay (ELISA) were used to confirm clinically diagnosed cases of WA-MCF. A latent
class model (LCM) was used to evaluate the diagnostic parameters of clinical diagnosis and the tests in the absence
of a gold standard.
Results: By PCR, 94% (95% C.I. 89–97%) of clinically affected animals were positive to WA-MCF while 63% (95% C.I.
54–71%) were positive by indirect ELISA. The LCM demonstrated the indirect ELISA had poor sensitivity 63.3% (95%
PCI 54.4–71.7%) and specificity 62.6% (95% PCI 39.2–84.9%) while the nested PCR performed better with sensitivity
96.1% (95% PCI 90.7–99.7%) and specificity 92.9% (95% PCI 76.1–99.8%). The sensitivity and specificity of clinical
diagnosis were 99.1% (95% PCI 96.8–100.0%) and 71.5% (95% PCI 48.0–97.2%) respectively.
Conclusions: Clinical diagnosis was demonstrated to be an effective method to identify affected animals although
animals may be incorrectly classified resulting in financial loss. The study revealed indirect ELISA as a poor test and
nested PCR to be a more appropriate confirmatory test for diagnosing acute WA-MCF. However, the logistics of
PCR make it unsuitable for field diagnosis of WA-MCF. The future of WA-MCF diagnosis should be aimed at
development of penside techniques, which will allow for fast detection in the field.
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Background
Malignant catarrhal fever (MCF) is a fatal viral illness of
cattle [1]. The causative viruses of MCF belong to sub-
family Gammaherpesvirinae, [2] genus Macavirus [3].
Worldwide there are two main viruses responsible for
MCF in cattle; these are alcelaphine herpesvirus 1
(AlHV-1), resulting in wildebeest associated malignant
catarrhal fever (WA-MCF), and ovine herpesvirus 2
(OvHV-2), resulting in sheep (Ovies aries) associated
malignant catarrhal fever (SA-MCF). WA-MCF primar-
ily occurs in sub-Saharan Africa and is confined to geo-
graphical regions where cattle graze with wildebeest [4].
Both blue and black wildebeest (Connochaetes testauri-
nus and C. gnou respectively) exist as natural hosts for
AlHV-1 [4].
There are yearly epidemics of WA-MCF in Kenya that
normally coincide with the wildebeest calving season [4]
with peak incidence occurring between March and June
[5]. The south western region of Kenya forms the loca-
tion of the three major wildebeest areas [4]. These are
the Maasai Mara ecosystem, including the Maasai Mara
National Reserve, extending into the Serengeti in
Tanzania; the Athi-Kaputiei environment including the
Nairobi National Park, and the Athi-Kaputiei plains; and
the Amboseli-Kilimanjaro ecosystem including the
Amboseli National Park and extending into Mt. Kiliman-
jaro in Tanzania [6–8]. In the field, diagnosis is by clin-
ical signs, which include oculonasal discharge, sudden
fever, corneal opacity, swollen lymph nodes, conjunctiv-
itis and erosive mucosal lesions in the upper respiratory
tract [9]. Differential diagnoses include bovine viral diar-
rhea (BVD)/mucosal disease, rinderpest, foot and mouth
disease (FMD), bluetongue and vesicular stomatitis. La-
boratory diagnosis is confirmed by positive serology or
PCR [10]. The definitive diagnoses are confirmed
through post mortem histopathological analysis of sam-
ples from dead cattle.
Several diagnostic tests for the detection of antibodies
to MCF viruses have been described [11]. These assays
use AlHV-1 as the antigen since this virus can be propa-
gated in vitro [11]. Serological tests used to identify
AlHV-1 infection include indirect ELISA [12, 13], com-
petitive inhibition (CI)- ELISA [14–16], virus
neutralization test (VNT) [12, 17] and indirect fluores-
cent antibody test [18]. The indirect ELISA depends on
a polyclonal response, which may be more robust in de-
tecting sick animals with partial or low antibody titres
compared with the CI-ELISA [13]. In MCF-susceptible
hosts like cattle, no virus-neutralizing antibody response
is induced, hence antibodies are detected using ELISA,
indirect immunofluorescence or Western blot [10].
An important tool for the molecular diagnosis of MCF
is PCR [11]. The first PCR assay for detecting AlHV-1
deoxyribonucleic acid (DNA) was described in 1990 [19]
and since then several DNA based assays have been de-
veloped [11]. These can differentiate AlHV-1 from other
macaviruses and have higher diagnostic sensitivity than
ELISA assays for diagnosis of MCF [4]. DNA based as-
says previously used for the detection of AlHV-1 include
nested PCR [20, 21], consensus PCR [11] and real time
PCR [22, 23] .
The World Organization for Animal Health (OIE) no
longer classifies WA-MCF as a trans boundary or notifi-
able disease, however it is of importance in Kenya in re-
gions where cattle co-graze with wildebeest. WA-MCF is
viewed as a significant cattle illness in sub Saharan Af-
rica with the highest impact on the livelihoods of
cattle-keeping communities [24]. The disease has direct
impacts on both commercial and smallholder farmers
whose economic livelihoods are affected by the death of
their cattle and additionally the loss of income from milk
and beef sales [24, 25].
There is currently no vaccine or treatment available
for WA-MCF [4]. The current control method for
WA-MCF in affected regions is preventing interaction
between cattle and wildebeest carriers [4, 5]. Cattle
owners attempt to reduce losses through disposal of sick
cattle or through disease avoidance strategies [4].
WA-MCF affected cattle will be sold at less than 50% of
the market value of healthy cattle [5, 24]. Avoidance
strategies mean that cattle-keepers graze their animals
on poorer pastures away from wildebeests [4]. The en-
ergy requirements during cattle movement over hun-
dreds of kilometers and poor quality of alternative
pastures reduce milk production and affect body condi-
tion reducing market value of cattle [25]. There are also
labour and travel related costs of avoiding WA-MCF
with family members spending up to three months away
from home [25].
The annual incidence of WA-MCF in Kenya is esti-
mated to be 3 to 12% [24]. The absence of a simple and
cost effective diagnostic test for AlHV-1 may contribute
to underreporting and misdiagnosis of WA-MCF cases
and may explain the high variability in the reported an-
nual WA-MCF incidence rates in sub-Saharan Africa
[4]. Currently cattle keepers clinically diagnose animals
with WA-MCF without laboratory confirmation [5]. The
objective of this study was to report the impact of
WA-MCF on a commercial ranch and assess the per-
formance of clinical diagnosis compared to laboratory
diagnosis as a disease management tool.
Results
Descriptive results
2014 WA-MCF outbreak
The 2014 WA-MCF outbreak at Kapiti Plains Ranch
started on May 7th (week 19 of 2014) and ended July
31st in (week 31) affecting 215 animals (Fig. 1). The herd
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size at the beginning of the outbreak was 2467 animals.
The incidence of WA-MCF in 2014 was 8.7 (95% C.I.
7.6–9.9) cases per hundred animals per year (Add-
itional file 1). The estimated direct losses to Kapiti Plains
Ranch were estimated ~ US$64,500.
There was no significant difference in WA-MCF inci-
dence between sexes, OR 1.00 (95% C.I. 0.71–1.37).
However, there was a significant difference in WA-MCF
incidence between age groups with steers, heifers and
cows more likely to have WA-MCF compared to calves.
The OR for steers was 4.53 (95% C.I. 2.29–10.03), heifers
3.85 (95% C.I. 2.00–8.37), and cows 2.79 (95% C.I. 1.44–
6.07) respectively (Additional file 2).
2015 WA-MCF outbreak
The 2015 outbreak started on April 2nd (week 14 of
2015) and ended June 30th (week 27) involving 78 ani-
mals (Fig. 1). The herd size at the beginning of the out-
break was 2106. The incidence in 2015 was 3.7 (95% C.I.
3.0–4.6) cases per hundred animals per year (Additional
file 1). The estimated direct losses to Kapiti Plains Ranch
were estimated ~US$23,400.
There was a significant difference in WA-MCF inci-
dence between sexes, with males having an OR of 0.38
(95% C.I. 0.16–0.78) compared to females. There was no
significant difference between the incidence of
WA-MCF cases within the age groups although there
was a positive relationship with heifers and cows more
likely to have WA-MCF compared to calves. The OR for
heifers was 1.72 (95% C.I. 0.86–3.64) and cows 1.49
(95% C.I. 0.76–3.11) respectively (Additional file 2).
2016 WA-MCF outbreak
The outbreak in 2016 started on March 29th (week 13
of 2016) and ended September 19th (week 37) involving
32 animals (Fig. 1). The herd size at the beginning of the
outbreak was 2069 animals. The incidence of WA-MCF
in 2016 was 1.5 (95% C.I. 1.1–2.2) cases per hundred an-
imals per year (Additional file 1). The estimated direct
losses to Kapiti Plains Ranch were estimated ~US$9600.
There was no significant difference between sexes with
respect to WA-MCF incidence, males having an OR 0.45
(95% C.I. 0.13–1.15). There was a positive but not a sig-
nificant relationship between age group and WA-MCF
incidence with cows and steers being more likely to have
WA-MCF compared to calves, OR 2.98 (95% C.I. 0.88–
18.60) and 2.29 (95% C.I. 3.7–17.57) respectively
(Additional file 2).
Laboratory results
A total of 123 samples were collected from 325 clinically
affected animals between 2014 and 2016. Samples were
tested using nested PCR and indirect ELISA. Of the 123
clinically diagnosed samples, 116 samples were positive
by nested PCR, while 77 were positive by indirect ELISA
(Table 1). Fifty-one samples were collected from clinic-
ally healthy animals in 2016. Of these, none were posi-
tive by nested PCR, while 3 were positive by indirect
ELISA (Table 1). The individual results for each animal
are available in Additional file 3.
Using all samples, a comparison of indirect ELISA to
nested PCR as the gold standard revealed its sensitivity
and specificity to be 63.8% (95% C.I. 54.4–72.5%) and
89.7% (95% C.I. 78.8–86.1%) respectively (Table 2). A
Fig. 1 Epidemic curve of malignant catarrhal fever at Kapiti Plains Ranch, 2014–2016 demonstrating the number of cases per week in each
year studied
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kappa value of 0.47 was obtained which revealed moder-
ate agreement between these two tests.
Bayesian Agreement Index (BAI)
The diagnostic parameters of both indirect ELISA and
nested PCR for all samples were evaluated in the ab-
sence of a gold standard using the BAI. This revealed
agreement for these two assays to be better in the posi-
tive than in the negative direction with a BAI of 75.5%
(95% BCI 69.0–82.0%) in the positive agreement and
68.4% (95% BCI 59.0–76.0%) in the negative direction.
Latent class model
The posterior estimates of sensitivity and specificity for
each diagnostic are given in Table 3 and the distributions
are plotted in Fig. 2. The results suggest that the indirect
ELISA is less appropriate as a diagnostic test in clinically
ill animals, presumably because they may have not
mounted an antibody response, with a sensitivity of
63.3% (95% PCI 54.4–71.1%) and specificity of 62.6%
(95% PCI 39.2–84.9%) while the nested PCR is more ap-
propriate with a sensitivity of 96.1% (95% PCI 90.7–
99.7%) and specificity of 92.9% (95% PCI 76.1–99.8%).
The sensitivity and specificity of clinical diagnosis was
99.1% (95% PCI 96.8–100.0%) and 71.5% (95% PCI
48.0–97.2%), respectively.
Discussion
The outbreaks of WA-MCF in 2014 and 2015 occurred
between the months of April and July. This coincides
with the period of the highest transmission of WA-MCF
in Kenya reported between March and June [4]. The
outbreak in 2016 was the longest and occurred between
the months of March to September. Changes in rainfall
and pasture availability are likely to affect wildebeest
calving seasons and this may explain the variation in the
timing of outbreaks. Increased stress on wildebeest
through pregnancy or nutritional deficits can also result
in longer periods of transmission [4]. In addition, out-
breaks that occur from September to November in
Kenya may be due to cattle undergoing stress because of
cold weather in the “winter” period (June–August) and
increased susceptibility to infection [4].
The incidence of WA-MCF in 2014 was 8.7% and in
2015 was 3.7%. This agrees with previous estimates of
the incidence of WA-MCF in Kenya to be 3–12% [24].
The reduction in incidence between 2014 and 2015 was
likely due to the implementation of wildebeest avoidance
measures to reduce contact between cattle and wilde-
beest on the ranch, including fencing and actively graz-
ing cattle away from wildebeest herds. The incidence in
2016 (1.5%) was less than previous years and this reflects
the lower numbers of wildebeest observed on the ranch
in 2016. The reduced numbers of wildebeest on the ranch
in 2016 may have been the result of drought [26]. Previous
research in the study area has demonstrated that wilde-
beest migrate into and out of the area depending on plant
biomass, which is dependent on rainfall [27]. In addition,
recent changes to land use in Kenya, including subdivision
and fencing, have disrupted wildebeest migration patterns
[28]. This could result in decreased transmission if wilde-
beests are prevented from returning to preferred grazing
areas or increased transmission through increasing the
number of non-migrating wildebeest populations close to
cattle herds.
The results of this study confirm earlier reports that
all age classes of cattle are susceptible to WA-MCF [5].
Steers, heifers and cows were more likely to develop
WA-MCF compared to the calves in 2014, while heifers
and cows were more likely to develop WA-MCF
Table 1 Overall results of PCR and ELISA for WA-MCF cases and clinically negative animals collected between 2014 and 2016
Clinically positive Clinically negative All samples
PCR positive PCR negative PCR positive PCR negative PCR positive PCR negative
ELISA positive 74 3 0 3 74 6
ELISA negative 42 4 0 48 42 52
Total 116 7 0 51 116 58
Table 2 Diagnostic test parameters for indirect ELISA using
nested PCR as a gold standard
Parameter Result 95% C.I
Sensitivity 63.8 54.4–72.5
Specificity 89.7 78.8–96.1
Positive Likelihood Ratio (PLR) 6.2 2.9–13.3
Negative Likelihood Ratio (NLR) 0.4 0.3–0.5
Positive Predictive Value (PPV) 92.5% 85.1–96.4
Negative Predictive Value (NPV) 55.3% 48.9–61.6
Table 3 Posterior Estimations of Diagnostic Test Parameters
with 95% Bayesian Credibility Intervals
Parameter Posterior estimate % (95% PCI)
Sensitivity ELISA 63.3 (54.4–71.7)
Sensitivity PCR 96.1 (90.7–99.7)
Sensitivity Clinical diagnosis 99.1 (96.8–100.0)
Specificity ELISA 62.6 (39.3–84.9)
Specificity PCR 92.9 (76.1–99.8)
Specificity Clinical Diagnosis 71.5 (48.0–97.2)
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compared to the calves in 2015. This is similar to a pre-
vious study in Tanzania where 36% of respondents indi-
cated that the disease affected mainly adults [5]. Calves
were less likely to be affected than other age classes.
Calves tend to be kept near the homestead and hence
may not spend as much time as adults in the wildebeest
grazing areas [5], and can also be suckling rather than
grazing.
This study demonstrated that when laboratory con-
firmation of clinical diagnosis is required, nested PCR is
a more effective tool for diagnosing WA-MCF than the
indirect ELISA. The effectiveness of PCR has been re-
ported previously [10]. However, the nested PCR is ex-
pensive, requiring specialized equipment and trained
personnel, which means it is not easily accessible. The
poor performance of the ELISA is likely due to the lack
of antibody production in some cattle with WA-MCF,
since susceptible animals may fail to develop measurable
levels of antibody before death [12, 29]. This is reflected
in the high positive predictive value of the ELISA, show-
ing that a positive serological test is good evidence to
support a diagnosis of WA-MCF whereas a negative test
has no predictive value. This is also supported by the
BAI which demonstrated a reasonable agreement be-
tween the indirect ELISA and the PCR in detecting
positive cases and poorer agreement between the tests in
detecting negative cases [30].
This study has provided a clearer understanding of the
serological response to WA-MCF in a field setting. Of
123 clinically affected cattle, 77 were ELISA-positive,
suggesting that almost two-thirds of cattle with
PCR-confirmed WA-MCF seroconvert during the clin-
ical course of disease. Previous research has indicated a
similar serological response in cattle exposed to
SA-MCF [15].
There were six ELISA-positive animals/PCR-negative
animals. These results may indicate subclinical infection,
recovered animals or animals infected with an antigeni-
cally cross-reactive herpesvirus. Subclinical infection of
cattle with SA-MCF has been reported previously [16, 31].
However a previous serosurvey for WA-MCF in Tanzania
only detected 1% seropositive cattle [32]. The role of sub-
clinically infected animals in the epidemiology of
WA-MCF in east Africa warrants further investigation.
This study highlighted the value of clinical diagnosis
for confirming WA-MCF in cattle. The LCM demon-
strated clinical diagnosis to have high sensitivity. Previ-
ous studies employing clinical diagnosis include a study
in Northern Tanzania [33] and an outbreak of WA-MCF
in Ankole cattle in a zoological park [34]. Clinical
Fig. 2 Posterior Probability Density Plots for Estimated Parameters, Se/Sp [1] = Clinical diagnosis, Se/Sp [2] = PCR, Se/Sp [3] = ELISA,
p = sample prevalence
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diagnosis is still the most accessible tool to the majority
of cattle-keepers.
The reduced specificity of clinical diagnosis highlights
the potential for non-MCF cases to be misclassified.
Since some of the WA-MCF clinical signs are
non-specific (fever, depression anorexia, diarrhoea and
bilateral corneal opacity) there is the potential for dis-
eases with similar clinical presentations, such as East
Coast fever (ECF), to be misdiagnosed as WA-MCF [5].
These animals may be sold at reduced costs when alter-
native treatments might be more appropriate. The costs
of WA-MCF outbreaks are direct through death of ani-
mals and loss of production. Some money can be
recouped by selling acutely sick animals at 50% market
value [5, 24]. The direct costs to Kapiti Plains Ranch be-
tween 2014 and 2016 were estimated to be US$97,500.
The four animals classified as WA-MCF cases by clinical
diagnosis but PCR and ELISA negative resulted in
US$1200 loss. The sale of non-MCF cases could be
avoided with improved diagnostics.
Conclusion
The practicality of WA-MCF diagnosis in the field relies
on clinical signs. This study demonstrates that clinical
diagnosis is an effective method to identify affected ani-
mals. However, the possibility of incorrectly classifying
animals based on clinical signs may result in unneces-
sary financial loss. Indirect ELISA was shown to be a
poor test in comparison to nested PCR, which is a more
appropriate confirmatory test for acute WA-MCF. The
future of WA-MCF diagnosis should be aimed at devel-
oping penside techniques for fast detection in the field.
Methods
Study area
Kapiti Plains Ranch Limited is 33,800 acre ranch located
in the Athi-Kaputiei plains 40 km east of Nairobi at
1.633333°S and 37.145267°E. It lies between 1646 to
1911 m above sea level. The area experiences two short
rainy seasons in March–May and again in October–De-
cember. Kapiti comprises extensive open grassland and
is described as a semi-arid zone. Cattle and sheep are
the main livestock species farmed on the land. The live-
stock graze together with multiple wild herbivore spe-
cies, including: wildebeest, hartebeest, Thomson’s and
Grant’s gazelle, impala, zebra, ostrich, eland and giraffe.
Historically, WA-MCF cases in cattle have been docu-
mented during and shortly after the wildebeest calving
season from February to July.
Study population
Kapiti Plains Ranch has between 2000 and 2500 head of
cattle. These are predominantly of the Boran breed with
some Boran-Friesian crosses.
Ethical considerations
The International Livestock Research Institute (ILRI) in-
stitutional veterinarian or a technician under instruction
from the veterinarian collected samples from clinically
affected animals. The collection of diagnostic specimens
from clinically sick animals did not require ethical re-
view. Permission to sample animals was granted by the
Kapiti Plains Ranch management and the registered resi-
dent veterinarian. Suspect cases of WA-MCF were sold
for slaughter, as is the normal practice at the Kapiti
Plains Ranch. Post mortem examinations were con-
ducted on two animals that died suddenly in 2014 and
one in 2016; the cause of death was confirmed to be
WA-MCF. The pathological findings are not reported
here. Clinically healthy animals were sampled during a
concurrent vaccine study reviewed and approved by the
ILRI Institutional Animal Care and Use Committee
(IACUC) 2016–02; the Directorate of Veterinary Ser-
vices, Republic of Kenya granted approval for the vac-
cine trial (VACC/I/VOL.XV/79).
Sampling method and sample collection
Between 2014 and 2016, 325 cases of WA-MCF were re-
ported at Kapiti Plains Ranch. Diagnosis was based on
clinical signs including pyrexia, bilateral corneal opacity,
serosanguinous nasal discharge and lachrymation. Add-
itional clinical signs associated with WA-MCF were also
considered but not observed in all cases. These included
dyspnea/coughing, inappetence, neurological signs, sali-
vation and weakness. Information regarding age and
gender were recorded for each animal. Blood samples
were opportunistically collected from 123 cases of clinic-
ally suspected WA-MCF and 51 clinically healthy
animals.
Blood samples were collected by jugular venipuncture
directly into 10ml plain and 10 ml Ethylenediaminetet-
raacetic acid (EDTA) vacutainer tubes (Becton Dickin-
son). The tubes were placed in a cool box containing ice
packs and transported to ILRI.
Laboratory analysis
Serology
Sera were separated by centrifugation at 3000 rpm for
20min at 4 °C (Avanti J-E Centrifuge, Beckman Coulter,
USA). Sera were screened for antibodies to WA-MCF by
indirect ELISA [12]. Ninety-six-well microtitre plates
(Greiner Bio-One, Austria) were coated with 50 μL of
5 μg/mL of virus positive or negative ELISA antigen in
0.1M carbonate buffer of pH 9.6. Virus-positive and
negative ELISA coating antigens were produced at the
Moredun Research Institute from cell-free culture fluid
of bovine turbinate (BT) cells infected with attenuated
AlHV-1 C500 and from uninfected BT cells respectively
[12]. The plates were covered with parafilm and left
Orono et al. BMC Veterinary Research           (2019) 15:69 Page 6 of 10
overnight at 4 °C. The plates were then washed six times
with phosphate buffered saline (PBS) and 0.02% Tween
20. This was followed by blocking each well with 100 μL
of 4% non fat dried milk/PBS, covering with parafilm for
one hour at room temperature. The plates were then
washed twice with PBS/Tween 20. An aliquot of 50 μL
of sample sera diluted in 2% non fat dried milk/PBS/
Tween 20 (1:500) was then added in duplicate to pairs
of positive and negative antigen wells. Known positive
and negative serum samples were included in all plates
as controls. The plates were covered with parafilm and
left for 1.5 h at room temperature. The plates were then
washed six times with PBS/Tween 20. This was followed
with the addition of 50 μL per well of 1:1000 rabbit anti-
bovine IgG-horseradish peroxidase (HRP) (Sigma Al-
drich, USA) diluted in 2% non fat dried milk/PBS/
Tween 20 and left for one hour at room temperature
after covering with parafilm. The plates were washed six
times with PBS/Tween 20. Tetramethylbenzidine(TMB)
substrate (50 μL) was added to each well and colour
change allowed to develop for five minutes. The reaction
was stopped by adding 50 μl of 0.1M hydrochloric acid
in every well. The plates were read by at 450 nm for
evaluation of the optical densities (OD) (Synergy HT,
Biotek, USA). ELISA values were calculated by subtract-
ing the mean of the negative antigen OD values from
the mean of the positive antigen OD values for every
sample. Inter-plate variations were adjusted by a correc-
tion factor (CF), which was applied to all of the plates
that used the same positive and negative control sera
over the screening period. The first plate run in a se-
quence with the same negative and positive controls was
used in calculating the CF. The CF was calculated from
the mean ELISA value of the positive and negative con-
trols from the first plate by the equation below, which
was applied to all the subsequent plates.
Correction factor ¼ P0−N0ð Þ=Pt−Nt
Where: P0 =Mean of the positive control sera from
plate 1.
N0 =Mean of the negative control sera from plate 1.
Pt =Mean of the positive control sera from plate on
test.
Nt =Mean of the negative control sera from plate on
test.
The cutoff was calculated by taking the mean ELISA
values of a plate of known negative samples plus three
standard deviations.
DNA extractions
DNA was extracted from 300 μL frozen EDTA-whole
blood using the Qiagen Flexigene kit (Qiagen, Venlo,
Netherlands). Where frozen EDTA-whole blood samples
were not available DNA was extracted from 200 μL
frozen sera using the High Pure Viral Nucleic Acid
kit (Roche Life Sciences, Basel, Switzerland) DNA was
extracted according to the manufacturer’s instructions
and eluted in 100 μL elution buffer and stored at
minus 20 °C.
Nested PCR
Amplification reactions were performed using previously
described primers [21]. The PCR reaction mix was 25 μL
and contained 12.5 μL of oneTaq Universal Master Mix
(New England Biolabs; containing OneTaq® DNA poly-
merase, dNTPs, buffer components), 5 pmol forward pri-
mer, 5 pmol reverse primer and a minimum of 50 ng of
sample DNA. The initial round of nested PCR was per-
formed using outer forward and outer reverse primers,
C500–1: TACGGGTGCCCTGACATTTCATCTCTTTT
G; and C500–2: ATAACTGGTTGATGTGGCAGATGC
ATCTAT respectively.
The second round amplification (274 basepair (bp)
DNA fragments) used the first round product (2 μL), with
inner forward and inner reverse primers, C500–3: TCTG
GCCCGTGCTGCAGCAAGACTCTCAG; and C500–4:
TATAGTAGAATCCCGTCTGAGTGGTAGCTG.
Thermocycling conditions for both rounds of amplifi-
cation were: 95 °C for 5 min; followed by 34 cycles of 94 °
C for 1 min; 55 °C for 1 min; 72 °C for 2 min; and 72 °C
for 7 min. PCR products (6 μL) were electrophoresed at
80 V through 2.0% (w/v) agarose containing 4 μL GelRed
(Biotium, 10,000x) per 100 ml gel. Gels were photo-
graphed by ultraviolet light for PCR product analysis.
The positive control was DNA extracted from the blood
of cattle that were confirmed to have died of WA-MCF.
Sterile water served as negative controls.
Statistical analysis
Data was managed in Microsoft (MS) Excel (Microsoft
Corp., 2010). Descriptive statistics and graphs were pro-
duced in MS Excel. Prevalence estimates were calculated
using the trueprev function in the prevalence package
[35] in R environment for statistical computing, version
3.4.0 (http://cran.r-project.org/). The logistic regression
analysis was conducted using the glm function in the
base package of R. Odds ratios (OR) were calculated and
P values ≤0.05 were considered significant. Estimate of
financial losses were calculated as 50% of the value of a
mature Boran animal (US$600) multiplied by the num-
ber of animals disposed/sold due to WA-MCF in each
year.
Diagnostic test performance
Comparison between the diagnostic tests was conducted
using four methods.
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1. The Cohen kappa statistic was used to assess the
agreement between PCR and indirect ELISA with
scores divided into < 0.2: slight agreement, 0.2–0.4:
fair agreement, 0.4–0.6: moderate agreement, 0.6–
0.8: substantial agreement and > 0.8: almost perfect
agreement [36].
2. The relative sensitivity (Se) and specificity (Sp) of
indirect ELISA was calculated using the nested PCR
as a gold standard [36].
3. The Bayesian Agreement Index (BAI) framework
was also performed in the R software environment
to determine the level of agreement between ELISA
and PCR in the absence of a gold standard [37, 38]
4. A Hui-Walter latent class model was used to esti-
mate the sensitivity and specificity of clinical diag-
noses, nested PCR and indirect ELISA in the
absence of a gold-standard [39]. The model was
adapted for three tests in 1 population [40]. The la-
tent class approach assumes that none of the tests
is a “gold standard” [41] and the tests are condition-
ally independent, such that if the true disease status
of an animal is known, then the outcome of one test
does not change our confidence in the outcome of
the other test [40].
As previously described by Bronsvoort et al. (2006) the
Bayesian approach to the Hui-Walter model assumes
that for the ith subpopulation the tally (Oi) of the dif-
ferent amalgam of test results for three tests +/+/+,
+/+/−, +/−/+, etc., follow a multinomial distribution,
where Pri is a vector of probabilities of observing the
individual combinations of test results, S is number of
subpopulations, and T is the number of tests and:
Oi j Se jSp jpi  Multinomial Pri; nið Þfor i ¼ 1; 2;…::; S
and j ¼ 1; 2;…:;T
Probabilities for each test scenario can be derived using
the Se/Sp of the tests and prevalence (p) of the
population. The equation below is for three positive
tests:
Pr T1þ;T2þ;T 3þð Þ ¼ Se1Se2Se3pi þ 1−Sp1ð Þ
1−Sp2ð Þ 1−Sp3ð Þ 1−pið Þ
Estimates of test sensitivity and specificity were
incorporated into the Bayesian framework as priors to
inform posterior estimates. Uninformed, beta(1,1)
priors were given to the estimates for sensitivity and
specificity of clinical diagnosis and ELISA and beta(5,1)
priors for PCR. The sensitivity and specificity of PCR
for detecting WA-MCF has been reported to be 95–
97% and 94–100% respectively [42].
The model was built using the runjags package [43] to
call Just another Gibbs sampler (JAGS) software [44] in
R. A burn in period of 50,000 iterations was discarded
and every tenth iteration of the following 100,000 kept
for posterior inference [40]. Convergence was assessed
by visual inspection of the time-series plots and
Gelman-Rubin diagnostic plots using three chains with
different starting points [40]. Posterior means and 95%
credibility intervals were calculated for the Se and Sp of
the three tests.
Additional files
Additional file 1: Descriptive results of WA-MCF outbreaks at Kapiti
Plains Ranch from 2014 to 2016. This table shows the number of WA-
MCF cases between 2014 and 2016 classified by age, sex and breed.
(DOCX 15 kb)
Additional file 2: Results of the logistic regression analysis
demonstrating the relationship between WA-MCF infection, gender and
age group during outbreaks at Kapiti Plains Ranch 2014–2016. This table
shows the results of the logistic regression analysis to measure
associations between age, sex, breed and WA-MCF seropositivity
(DOCX 17 kb)
Additional file 3: Details for each animal sampled at Kapiti Plains Ranch
2014–2016 - identification, date of birth, sex, sampling date, breed,
samples available, clinical status and test results. Column headings: Brand,
animal identification; DOB, date of birth; Sex, M =male, F = female;
Sample date, date sample collected; Breed, Boran = Boran breed, Dairy =
Boran cross Friesian or Ayrshire; Blood, Yes = blood sample available for
testing, No = sample not available; Serum, Yes = serum sample available
for testing, No = sample not available; Clinical, Yes = animal presented
with clinical WA-MCF, No = animal did not have clinical signs; PCR,
Positive = positive test result, Negative = negative in all tests; ELISA,
Positive = positive ELISA value, Negative = negative in all tests.
(DOCX 43 kb)
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